Overview
This study aims to conduct a feasibility trial to examine the feasibility and acceptability of conducting a randomized controlled trial that evaluates the effect of the weight management intervention on anthropometric measures (body weight and BMI), dietary quality, physical activity levels, physical and psychosocial functioning, selfefficacy for weight loss and quality of life.
Description
The primary aim of the proposed study is to assess the feasibility and acceptability of conducting a randomized controlled trial (RCT) that evaluates an adaptive weight management intervention, tailored to Chinese cancer survivors with overweight/obesity after the completion of cancer survivorship care, to improve anthropometric measures (body weight and BMI), dietary quality, physical activity levels, physical and psychosocial functioning, self-efficacy for weight loss and quality of life. According to the Consolidation Standards of Reporting Trials (CONSORT) guidelines for reporting feasibility trials, hypothesis setting for a feasibility trial is not recommended, given that pilot trials are often underpowered to detect difference which instead should be the aim of the main trial.
Eligibility
Inclusion Criteria:
- Chinese cancer survivors attending the one-off face-to-face survivorship care clinic
- who are Cantonese- or Mandarin- speaking
- aged 18 or above
- diagnosed with early-stage disease (stage 0-II)
- have completed primary and adjuvant treatments such as chemotherapy and radiotherapy
- and with a BMI ≥ 23 kg/m2, as indicative as overweight or obesity using Asia-Pacific BMI cutoffs at 3-months reassessment
Exclusion Criteria:
- Non-Chinese survivors with advanced or metastatic disease
- who have communication difficulties, mobility impairment or cognitive disabilities